van Zijl P - Search Results

1

Mutagenicity profiles of newer amsacrine analogues with activity against solid tumours: comparison of microbial and mammalian systems.

Ferguson LR, van Zijl P, Baguley BC. Ferguson LR, et al. Among authors: van zijl p. Eur J Cancer Clin Oncol. 1989 Feb;25(2):255-61. doi: 10.1016/0277-5379(89)90017-5. Eur J Cancer Clin Oncol. 1989. PMID: 2649376

2

Mutagenic and clastogenic activity of nitracrine analogues in cultured V79 Chinese hamster cells.

Ferguson LR, van Zijl P. Ferguson LR, et al. Among authors: van zijl p. Mutat Res. 1988 Apr;204(4):655-63. doi: 10.1016/0165-1218(88)90069-9. Mutat Res. 1988. PMID: 3352647

3

Comparison of the mutagenicity of amsacrine with that of a new clinical analogue, CI-921.

Ferguson LR, van Zijl P, Baguley BC. Ferguson LR, et al. Among authors: van zijl p. Mutat Res. 1988 Feb;204(2):207-17. doi: 10.1016/0165-1218(88)90091-2. Mutat Res. 1988. PMID: 3278212

4

Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumour cells cultured from patients with ovarian cancer.

Baguley BC, Marshall ES, Whittaker JR, Dotchin MC, Nixon J, McCrystal MR, Finlay GJ, Matthews JH, Holdaway KM, van Zijl P. Baguley BC, et al. Among authors: van zijl p. Eur J Cancer. 1995;31A(2):230-7. doi: 10.1016/0959-8049(94)00472-h. Eur J Cancer. 1995. PMID: 7718330

5

Morphological transformation and chromosome damage by amsacrine in C3H/10T1/2 clone 8 cells.

Ferguson LR, van Zijl P, Nesnow S. Ferguson LR, et al. Among authors: van zijl p. Mutat Res. 1986 Jun;170(3):133-43. doi: 10.1016/0165-1218(86)90027-3. Mutat Res. 1986. PMID: 3754932

6

Condensed tannins induce micronuclei in cultured V79 Chinese hamster cells.

Ferguson LR, van Zijl P, Holloway WD, Jones WT. Ferguson LR, et al. Among authors: van zijl p. Mutat Res. 1985 Oct-Nov;158(1-2):89-95. doi: 10.1016/0165-1218(85)90102-8. Mutat Res. 1985. PMID: 3900722

7

An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours.

Hicks KO, Ohms SJ, van Zijl PL, Denny WA, Hunter PJ, Wilson WR. Hicks KO, et al. Among authors: van zijl pl. Br J Cancer. 1997;76(7):894-903. doi: 10.1038/bjc.1997.481. Br J Cancer. 1997. PMID: 9328149 Free PMC article.

8

Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Cytotoxicity, DNA binding, cellular uptake, and metabolism.

Siim BG, Hicks KO, Pullen SM, van Zijl PL, Denny WA, Wilson WR. Siim BG, et al. Among authors: van zijl pl. Biochem Pharmacol. 2000 Oct 1;60(7):969-78. doi: 10.1016/s0006-2952(00)00420-2. Biochem Pharmacol. 2000. PMID: 10974206

9

Bis-bioreductive agents as hypoxia-selective cytotoxins: nitracrine N-oxide.

Wilson WR, Van Zijl P, Denny WA. Wilson WR, et al. Among authors: van zijl p. Int J Radiat Oncol Biol Phys. 1992;22(4):693-6. doi: 10.1016/0360-3016(92)90505-c. Int J Radiat Oncol Biol Phys. 1992. PMID: 1544839

10

Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.

Lee HH, Wilson WR, Ferry DM, van Zijl P, Pullen SM, Denny WA. Lee HH, et al. Among authors: van zijl p. J Med Chem. 1996 Jun 21;39(13):2508-17. doi: 10.1021/jm9600104. J Med Chem. 1996. PMID: 8691448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

510 results

Search Page

Filters